Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Possible Goal for New Tuberculosis-Vaccine Identified

Published: Monday, July 08, 2013
Last Updated: Monday, July 08, 2013
Bookmark and Share
A new study shows for the first time the essential role of the molecule SOCS3 in the control of Tuberculosis.

This could have impact on the future development of a vaccine.

Tuberculosis is sometimes perceived as a feared killer of the past but is still a dreadful disease of mankind. One third of the world population is infected with the bacteria Mycobacterium tuberculosis that causes the disease. However, Tuberculosis is manifested only in approximately 10 percent of those infected. Still, about 2 million Tuberculosis patients die every year worldwide.

Mycobacterium tuberculosis multiplies inside white blood cells known as macrophages. In infected people who don't develop the Tuberculosis, the immune system either the bacteria or impairs bacterial multiplication. The exact mechanisms behind this are not known in detail, hampering the development of effective vaccines and treatments of the disease. Why the disease is manifested in some individual, but not in others, is not completely understood.

The recent study shows that a molecule called SOCS3 is required for control of the infection. The discovery was done using an experimental infection of mice genetically modified so that they do not express SOCS3 in different immune cells. These mice were dramatically susceptible to the infection with Mycobacterium tuberculosis.

"Like a soldier with two guns the molecule SOCS3 engages in different ways in the combat against Mycobacterium tuberculosis. We were stunned by the fact that the same molecule independently controls diverse mechanisms in different cell types," says Martin Rottenberg, from the Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet.

The control of Tuberculosis is hampered by the appearance of antibiotic-resistant strains. Moreover, the Tuberculosis vaccine, developed almost 100 years ago, shows low efficiency against the most common pulmonary disease. An improved understanding of how our immune responses control the infection might be used for the design of new vaccines.

"We speculate that SOCS3 could be a new target for vaccines to improve the protection against Tuberculosis," says Martin Rottenberg.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,900+ scientific posters on ePosters
  • More Than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Short RNA Molecules Mapped in Single Cell
Researchers have successfully measured the numbers of short, non-coding, RNA sequences in individual embryonic stem cells.
Wednesday, November 02, 2016
Genetic Impact of Endurance Training
Research has found that endurance training changes genetic activity in thousands of genes, giving rise to large number of altered RNA variants.
Tuesday, September 27, 2016
Why Pneumococci Primarily Affects Human
A sugar molecule variant may explain why pneumococcal infections occur more frequently in humans compared to other animals.
Monday, September 05, 2016
A New Method Simplifies Blood Biomarker Discovery And Analysis
Scientists at Karolinska Institutet in collaboration with Estonian Competence Centre on Health Technologies have developed a new gene expression analysis method to widen the usage of blood in biomarker discovery and analysis.
Tuesday, August 16, 2016
Insights into Early Human Embryo Development
Researchers at Karolinska Institutet and the Ludwig Cancer Research in Stockholm have conducted a detailed molecular analysis of the embryo’s first week of development.
Monday, April 11, 2016
Complex Grammar of the Genomic Language
A new study from Karolinska Institutet shows that the ‘grammar’ of the human genetic code is more complex than that of even the most intricately constructed spoken languages in the world.
Thursday, November 12, 2015
New Mechanism Discovered Behind Infant Epilepsy
Scientists at Karolinska Institutet and Karolinska University Hospital have discovered a new explanation for severe early infant epilepsy.
Monday, September 07, 2015
Stem Cells from Nerves Forming Teeth
Findings published in the scientific journal Nature.
Wednesday, July 30, 2014
Different Cell Mechanisms Behind Regenerated Limbs
Scientists at Karolinska Institutet have discovered that two separate species of salamander differ in the way their muscles grow back in lost body parts.
Tuesday, November 26, 2013
New European Vaccine Initiative
Leading organisations have joined forces to rapidly assess and communicate the benefits and risks of vaccines.
Tuesday, November 26, 2013
Synthetic mRNA can Induce Self-Repair and Regeneration of the Infarcted Heart
A team of scientists has instructing injured hearts in mice to heal by expressing a factor that triggers cardiovascular regeneration driven by native heart stem cells.
Monday, September 16, 2013
Technological Breakthrough Paves the Way for Better Drugs
Researchers have developed the first method for directly measuring the extent to which drugs reach their targets in the cell.
Monday, July 08, 2013
Trackable Drug-Filled Nanoparticles - a Potential Weapon against Cancer
Tiny particles filled with a drug could be a new tool for treating cancer in the future.
Monday, March 04, 2013
Learning the Alphabet of Controlling Gene Expression
Scientists at Karolinska Institutet have made a large step towards the understanding of how human genes are regulated.
Monday, January 21, 2013
New Hope for Setback-dogged Cancer Treatment
Researchers at Karolinska Institutet announce breakthrough in the study of how IGF-1 receptor-binding antibodies can help those with cancer.
Wednesday, November 28, 2012
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
BGI Sequences Gingko Tree, Revealing Large, Highly Repetitive Genome
Researchers at BGI have sequenced the more than 10-gigabase ginkgo genome to find a high number of repetitive sequences as well as a number of gene clusters that appear to be involved in defense mechanisms.
Survey of New York City Soil Uncovers Medicine-Making Microbes
Microbes have long been an invaluable source of new drugs. And to find more, we may have to look no further than the ground beneath our feet.
Accelerating the Detection of Foodborne Bacterial Outbreaks
The speed of diagnosis of foodborne bacterial outbreaks could be improved by a new technique developed by researchers at the Georgia Institute of Technology.
Making Personalized Medicine a Reality
Groundbreaking technique developed at McMaster University is helping to pave the way for advances in personalized medicine.
Scientists Identify Unique Genomic Features in Testicular Cancer
The findings may shed light on factors in other cancers that influence their sensitivity to chemotherapy.
Top 10 Life Science Innovations of 2016
2016 has seen the release of some truly innovative products. To help you digest these developments, The Scientist have listed their top picks for the year.
BioCision Forms MedCision
The new company will focus on technologies for the management and automation of vital clinical processes.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!